APO Research
Talk to an analyst

APO RESEARCH · REPORT

Computer-Aided Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Computer-Aided Drug Industry Growth and Trends Forecast to 2032

31 December 2025103 pages

Choose your research edition.

Industry ResearchComputer-Aided Drug Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Computer-Aided Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Computer-Aided Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Computer-Aided Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Computer-Aided Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

According to APO Research, the global Computer-Aided Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Computer-Aided Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Computer-Aided Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Computer-Aided Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Computer-Aided Drug market include Aaranya Biosciences Pvt. Ltd., Albany Molecular Research Inc., Charles River Laboratories International Inc., Chembio Discovery Inc., Chemical Computing Group ULC, Compchem Solutions Ltd., International Business Machines Corp., Kang Yusheng Information Technology Co. Ltd. and Market Positioning Of Vendors, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Computer-Aided Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Computer-Aided Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Computer-Aided Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Computer-Aided Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Computer-Aided Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Computer-Aided Drug Market by Company

Aaranya Biosciences Pvt. Ltd.

Albany Molecular Research Inc.

Charles River Laboratories International Inc.

Chembio Discovery Inc.

Chemical Computing Group ULC

Compchem Solutions Ltd.

International Business Machines Corp.

Kang Yusheng Information Technology Co. Ltd.

Market Positioning Of Vendors

Openeye Scientific Software Inc.

Pharmaron Beijing Co. Ltd.

Computer-Aided Drug Segment by Type

Structure Based Drug

Ligand Based Drug

Computer-Aided Drug Segment by Application

Oncological Disorders

Neurological Disorders

Other

Computer-Aided Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Computer-Aided Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Computer-Aided Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Computer-Aided Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Computer-Aided Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Computer-Aided Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Computer-Aided Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Computer-Aided Drug Market Share by Region (2021-2026) Table 4. Global Computer-Aided Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Computer-Aided Drug Market Share by Region (2027-2032) Table 6. Global Computer-Aided Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Computer-Aided Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Computer-Aided Drug Market Size Share by Type (2021-2026) Table 9. Global Computer-Aided Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Computer-Aided Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Computer-Aided Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Computer-Aided Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Computer-Aided Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Computer-Aided Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Computer-Aided Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Computer-Aided Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Computer-Aided Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Computer-Aided Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Computer-Aided Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Computer-Aided Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Computer-Aided Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Computer-Aided Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Computer-Aided Drug Market Size Share by Application (2021-2026) Table 24. Global Computer-Aided Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Computer-Aided Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Computer-Aided Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Computer-Aided Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Computer-Aided Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Computer-Aided Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Computer-Aided Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Computer-Aided Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Computer-Aided Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Computer-Aided Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Computer-Aided Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Computer-Aided Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Computer-Aided Drug Industry Trends Table 37. Computer-Aided Drug Industry Drivers Table 38. Computer-Aided Drug Industry Opportunities and Challenges Table 39. Computer-Aided Drug Industry Restraints Table 40. Global Computer-Aided Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Computer-Aided Drug Revenue Market Share by Company (2021-2026) Table 42. Global Computer-Aided Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Computer-Aided Drug Key Company Headquarters & Area Served Table 44. Global Computer-Aided Drug Company, Product Type & Application Table 45. Global Computer-Aided Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Computer-Aided Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Aaranya Biosciences Pvt. Ltd. Company Information Table 49. Aaranya Biosciences Pvt. Ltd. Business Overview Table 50. Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Product Portfolio Table 52. Aaranya Biosciences Pvt. Ltd. Recent Development Table 53. Albany Molecular Research Inc. Company Information Table 54. Albany Molecular Research Inc. Business Overview Table 55. Albany Molecular Research Inc. Computer-Aided Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Albany Molecular Research Inc. Computer-Aided Drug Product Portfolio Table 57. Albany Molecular Research Inc. Recent Development Table 58. Charles River Laboratories International Inc. Company Information Table 59. Charles River Laboratories International Inc. Business Overview Table 60. Charles River Laboratories International Inc. Computer-Aided Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Charles River Laboratories International Inc. Computer-Aided Drug Product Portfolio Table 62. Charles River Laboratories International Inc. Recent Development Table 63. Chembio Discovery Inc. Company Information Table 64. Chembio Discovery Inc. Business Overview Table 65. Chembio Discovery Inc. Computer-Aided Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Chembio Discovery Inc. Computer-Aided Drug Product Portfolio Table 67. Chembio Discovery Inc. Recent Development Table 68. Chemical Computing Group ULC Company Information Table 69. Chemical Computing Group ULC Business Overview Table 70. Chemical Computing Group ULC Computer-Aided Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Chemical Computing Group ULC Computer-Aided Drug Product Portfolio Table 72. Chemical Computing Group ULC Recent Development Table 73. Compchem Solutions Ltd. Company Information Table 74. Compchem Solutions Ltd. Business Overview Table 75. Compchem Solutions Ltd. Computer-Aided Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Compchem Solutions Ltd. Computer-Aided Drug Product Portfolio Table 77. Compchem Solutions Ltd. Recent Development Table 78. International Business Machines Corp. Company Information Table 79. International Business Machines Corp. Business Overview Table 80. International Business Machines Corp. Computer-Aided Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. International Business Machines Corp. Computer-Aided Drug Product Portfolio Table 82. International Business Machines Corp. Recent Development Table 83. Kang Yusheng Information Technology Co. Ltd. Company Information Table 84. Kang Yusheng Information Technology Co. Ltd. Business Overview Table 85. Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Product Portfolio Table 87. Kang Yusheng Information Technology Co. Ltd. Recent Development Table 88. Market Positioning Of Vendors Company Information Table 89. Market Positioning Of Vendors Business Overview Table 90. Market Positioning Of Vendors Computer-Aided Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Market Positioning Of Vendors Computer-Aided Drug Product Portfolio Table 92. Market Positioning Of Vendors Recent Development Table 93. Openeye Scientific Software Inc. Company Information Table 94. Openeye Scientific Software Inc. Business Overview Table 95. Openeye Scientific Software Inc. Computer-Aided Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Openeye Scientific Software Inc. Computer-Aided Drug Product Portfolio Table 97. Openeye Scientific Software Inc. Recent Development Table 98. Pharmaron Beijing Co. Ltd. Company Information Table 99. Pharmaron Beijing Co. Ltd. Business Overview Table 100. Pharmaron Beijing Co. Ltd. Computer-Aided Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Pharmaron Beijing Co. Ltd. Computer-Aided Drug Product Portfolio Table 102. Pharmaron Beijing Co. Ltd. Recent Development Table 103. North America Computer-Aided Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Computer-Aided Drug Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Computer-Aided Drug Market Share by Country (2021-2026) Table 106. North America Computer-Aided Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Computer-Aided Drug Market Share Forecast by Country (2027-2032) Table 108. Europe Computer-Aided Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Europe Computer-Aided Drug Market Size by Country (2021-2026) & (US$ Million) Table 110. Europe Computer-Aided Drug Market Share by Country (2021-2026) Table 111. Europe Computer-Aided Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Europe Computer-Aided Drug Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Computer-Aided Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Computer-Aided Drug Market Size by Country (2021-2026) & (US$ Million) Table 115. Asia-Pacific Computer-Aided Drug Market Share by Country (2021-2026) Table 116. Asia-Pacific Computer-Aided Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Asia-Pacific Computer-Aided Drug Market Share Forecast by Country (2027-2032) Table 118. Latin America Computer-Aided Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Latin America Computer-Aided Drug Market Size by Country (2021-2026) & (US$ Million) Table 120. Latin America Computer-Aided Drug Market Share by Country (2021-2026) Table 121. Latin America Computer-Aided Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Latin America Computer-Aided Drug Market Share Forecast by Country (2027-2032) Table 123. Middle East & Africa Computer-Aided Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Middle East & Africa Computer-Aided Drug Market Size by Country (2021-2026) & (US$ Million) Table 125. Middle East & Africa Computer-Aided Drug Market Share by Country (2021-2026) Table 126. Middle East & Africa Computer-Aided Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Middle East & Africa Computer-Aided Drug Market Share Forecast by Country (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Computer-Aided Drug Product Image Figure 3. Global Computer-Aided Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Computer-Aided Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Computer-Aided Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Computer-Aided Drug Market Share by Region (2021-2032) Figure 7. North America Computer-Aided Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Computer-Aided Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Computer-Aided Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Computer-Aided Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Computer-Aided Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Structure Based Drug Image Figure 13. Global Structure Based Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Ligand Based Drug Image Figure 15. Global Ligand Based Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Computer-Aided Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Computer-Aided Drug Market Share by Type 2025 VS 2032 Figure 18. North America Computer-Aided Drug Market Size Share by Type (2021-2032) Figure 19. Europe Computer-Aided Drug Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Computer-Aided Drug Market Size Share by Type (2021-2032) Figure 21. Latin America Computer-Aided Drug Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Computer-Aided Drug Market Size Share by Type (2021-2032) Figure 23. Oncological Disorders Image Figure 24. Global Oncological Disorders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Neurological Disorders Image Figure 26. Global Neurological Disorders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Other Image Figure 28. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Computer-Aided Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Computer-Aided Drug Market Share by Application 2025 VS 2032 Figure 31. North America Computer-Aided Drug Market Size Share by Application (2021-2032) Figure 32. Europe Computer-Aided Drug Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Computer-Aided Drug Market Size Share by Application (2021-2032) Figure 34. Latin America Computer-Aided Drug Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Computer-Aided Drug Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Computer-Aided Drug Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Computer-Aided Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Computer-Aided Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Computer-Aided Drug Market Share by Country (2021-2032) Figure 41. Europe Computer-Aided Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Computer-Aided Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Computer-Aided Drug Market Share by Country (2021-2032) Figure 44. Asia-Pacific Computer-Aided Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Computer-Aided Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Computer-Aided Drug Market Share by Country (2021-2032) Figure 47. Latin America Computer-Aided Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Computer-Aided Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Computer-Aided Drug Market Share by Country (2021-2032) Figure 50. Middle East & Africa Computer-Aided Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Computer-Aided Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Computer-Aided Drug Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Structure Based Drug
  • Ligand Based Drug
Applications
  • Oncological Disorders
  • Neurological Disorders
  • Other
Companies covered
  • Aaranya Biosciences Pvt. Ltd.
  • Albany Molecular Research Inc.
  • Charles River Laboratories International Inc.
  • Chembio Discovery Inc.
  • Chemical Computing Group ULC
  • Compchem Solutions Ltd.
  • International Business Machines Corp.
  • Kang Yusheng Information Technology Co. Ltd.
  • Market Positioning Of Vendors
  • Openeye Scientific Software Inc.
  • Pharmaron Beijing Co. Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Computer-Aided Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Computer-Aided Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Computer-Aided Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Computer-Aided Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Computer-Aided Drug Market Size (2021-2032)
  8. 1.5.1 North America Computer-Aided Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Computer-Aided Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Computer-Aided Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Computer-Aided Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Computer-Aided Drug Market Size Growth Rate (2021-2032)
2 Computer-Aided Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Structure Based Drug
  3. 2.1.2 Ligand Based Drug
  4. 2.2 Global Computer-Aided Drug Market Size by Type
  5. 2.2.1 Global Computer-Aided Drug Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Computer-Aided Drug Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Computer-Aided Drug Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Computer-Aided Drug Market Size by Regions
  9. 2.3.1 North America Computer-Aided Drug Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Computer-Aided Drug Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Computer-Aided Drug Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Computer-Aided Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Computer-Aided Drug Market Size Breakdown by Type (2021-2026)
3 Computer-Aided Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Oncological Disorders
  3. 3.1.2 Neurological Disorders
  4. 3.1.3 Other
  5. 3.2 Global Computer-Aided Drug Market Size by Application
  6. 3.2.1 Global Computer-Aided Drug Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Computer-Aided Drug Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Computer-Aided Drug Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Computer-Aided Drug Market Size by Regions
  10. 3.3.1 North America Computer-Aided Drug Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Computer-Aided Drug Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Computer-Aided Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Computer-Aided Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Computer-Aided Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Computer-Aided Drug Industry Trends
  2. 4.2 Computer-Aided Drug Industry Drivers
  3. 4.3 Computer-Aided Drug Industry Opportunities and Challenges
  4. 4.4 Computer-Aided Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Computer-Aided Drug Revenue (2021-2026)
  2. 5.2 Global Computer-Aided Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Computer-Aided Drug Key Company Headquarters & Area Served
  4. 5.4 Global Computer-Aided Drug Company, Product Type & Application
  5. 5.5 Global Computer-Aided Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Computer-Aided Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Computer-Aided Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Computer-Aided Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Aaranya Biosciences Pvt. Ltd.
  2. 6.1.1 Aaranya Biosciences Pvt. Ltd. Company Information
  3. 6.1.2 Aaranya Biosciences Pvt. Ltd. Business Overview
  4. 6.1.3 Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Product Portfolio
  6. 6.1.5 Aaranya Biosciences Pvt. Ltd. Recent Developments
  7. 6.2 Albany Molecular Research Inc.
  8. 6.2.1 Albany Molecular Research Inc. Company Information
  9. 6.2.2 Albany Molecular Research Inc. Business Overview
  10. 6.2.3 Albany Molecular Research Inc. Computer-Aided Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Albany Molecular Research Inc. Computer-Aided Drug Product Portfolio
  12. 6.2.5 Albany Molecular Research Inc. Recent Developments
  13. 6.3 Charles River Laboratories International Inc.
  14. 6.3.1 Charles River Laboratories International Inc. Company Information
  15. 6.3.2 Charles River Laboratories International Inc. Business Overview
  16. 6.3.3 Charles River Laboratories International Inc. Computer-Aided Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Charles River Laboratories International Inc. Computer-Aided Drug Product Portfolio
  18. 6.3.5 Charles River Laboratories International Inc. Recent Developments
  19. 6.4 Chembio Discovery Inc.
  20. 6.4.1 Chembio Discovery Inc. Company Information
  21. 6.4.2 Chembio Discovery Inc. Business Overview
  22. 6.4.3 Chembio Discovery Inc. Computer-Aided Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Chembio Discovery Inc. Computer-Aided Drug Product Portfolio
  24. 6.4.5 Chembio Discovery Inc. Recent Developments
  25. 6.5 Chemical Computing Group ULC
  26. 6.5.1 Chemical Computing Group ULC Company Information
  27. 6.5.2 Chemical Computing Group ULC Business Overview
  28. 6.5.3 Chemical Computing Group ULC Computer-Aided Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Chemical Computing Group ULC Computer-Aided Drug Product Portfolio
  30. 6.5.5 Chemical Computing Group ULC Recent Developments
  31. 6.6 Compchem Solutions Ltd.
  32. 6.6.1 Compchem Solutions Ltd. Company Information
  33. 6.6.2 Compchem Solutions Ltd. Business Overview
  34. 6.6.3 Compchem Solutions Ltd. Computer-Aided Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Compchem Solutions Ltd. Computer-Aided Drug Product Portfolio
  36. 6.6.5 Compchem Solutions Ltd. Recent Developments
  37. 6.7 International Business Machines Corp.
  38. 6.7.1 International Business Machines Corp. Company Information
  39. 6.7.2 International Business Machines Corp. Business Overview
  40. 6.7.3 International Business Machines Corp. Computer-Aided Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 International Business Machines Corp. Computer-Aided Drug Product Portfolio
  42. 6.7.5 International Business Machines Corp. Recent Developments
  43. 6.8 Kang Yusheng Information Technology Co. Ltd.
  44. 6.8.1 Kang Yusheng Information Technology Co. Ltd. Company Information
  45. 6.8.2 Kang Yusheng Information Technology Co. Ltd. Business Overview
  46. 6.8.3 Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Product Portfolio
  48. 6.8.5 Kang Yusheng Information Technology Co. Ltd. Recent Developments
  49. 6.9 Market Positioning Of Vendors
  50. 6.9.1 Market Positioning Of Vendors Company Information
  51. 6.9.2 Market Positioning Of Vendors Business Overview
  52. 6.9.3 Market Positioning Of Vendors Computer-Aided Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Market Positioning Of Vendors Computer-Aided Drug Product Portfolio
  54. 6.9.5 Market Positioning Of Vendors Recent Developments
  55. 6.10 Openeye Scientific Software Inc.
  56. 6.10.1 Openeye Scientific Software Inc. Company Information
  57. 6.10.2 Openeye Scientific Software Inc. Business Overview
  58. 6.10.3 Openeye Scientific Software Inc. Computer-Aided Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Openeye Scientific Software Inc. Computer-Aided Drug Product Portfolio
  60. 6.10.5 Openeye Scientific Software Inc. Recent Developments
  61. 6.11 Pharmaron Beijing Co. Ltd.
  62. 6.11.1 Pharmaron Beijing Co. Ltd. Company Information
  63. 6.11.2 Pharmaron Beijing Co. Ltd. Business Overview
  64. 6.11.3 Pharmaron Beijing Co. Ltd. Computer-Aided Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Pharmaron Beijing Co. Ltd. Computer-Aided Drug Product Portfolio
  66. 6.11.5 Pharmaron Beijing Co. Ltd. Recent Developments
7 North America
  1. 7.1 North America Computer-Aided Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Computer-Aided Drug Market Size by Country (2021-2026)
  3. 7.3 North America Computer-Aided Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Computer-Aided Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Computer-Aided Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Computer-Aided Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Computer-Aided Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Computer-Aided Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Computer-Aided Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Computer-Aided Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Computer-Aided Drug Market Size by Country (2021-2026)
  3. 10.3 South America Computer-Aided Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Computer-Aided Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Computer-Aided Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Computer-Aided Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst